Back to results
US 12,642,884 B1Granted
Sclerotherapy of venous blood vessels
AssigneeCroma-Pharma GmbH
InventorsHeinrich Magometschnigg, Michaela Magometschnigg
Life of this patent
Estimating the term…
Abstract
Sclerosing agent for use in treating a varicose, reticular or spider vein, wherein the sclerosing agent is administered in a formulation further comprising a water-soluble cellulose derivative, pharmaceutical composition comprising a sclerosing agent and a water-soluble cellulose derivative as well as a kit or a method for producing a foam comprising a sclerosing agent and a water-soluble cellulose derivative.
Claims9
A pharmaceutical composition comprising:
- a sclerosing agent;
- and
- a water-soluble cellulose derivative,
- wherein the sclerosing agent is polidocanol,
- wherein the sclerosing agent is included at a concentration of about 0.1% (w/v) to about 1.0% (w/v), and the water-soluble cellulose derivative is included at a concentration of greater than 1.3% (w/v).
2 more elements
A pharmaceutical composition comprising:
- a sclerosing agent;
- and
- a water-soluble cellulose derivative,
- wherein the sclerosing agent is polidocanol, and the sclerosing agent is hydroxypropyl methylcellulose,
- wherein the sclerosing agent is included at a concentration of from about 0.1% (w/v) to about 1.0% (w/v),
- wherein the water-soluble cellulose derivative is included at a concentration of greater than 1.3% (w/v) and lower than 2.5% (w/v), and
- wherein the composition is a sterile aqueous solution.
4 more elements
Dependencies are inferred from the claim text.